The four children, who were excluded from the study, were given adequate treatment accordingly. The mean age of children was 1.8 years and 1.6 years in the Group A and B respectively. Almost, 73.3% boys in Group A and 60% boys in Group B were there. 2 The interest rate and Annual Percentage Yield (APY) will be disclosed in your account-opening documents, which you will receive after funding your Account. The interest rate and APY for your CD will be fixed and will either be (i) the rate reflected at application submission or (ii) the rate being offered when your CD is funded, whichever is higher. All CDs must be funded within 60 calendar days from the time we approve your application or will be subject to closure.
How do I contact American Express?
- Several published studies 6,11-14 show the efficacy of amoxicillin-clavulanate potassium for the treatment of PAOM.
- Few studies have evaluated efficacy of oral cephalosporins in treatment of PAOM 14-17.
- Children were evaluated clinically at baseline (day 0) and at subsequent follow-up visits on Days five and 10.
- Cefpodoxime is a wide spectrum oral third generation cephalosporin.
- Earn more interest than your average savings account – and watch your money grow.
Children were evaluated clinically at baseline (day 0) and at subsequent follow-up visits on Days five and 10. A high-yield savings account (HYSA) generally offers higher interest rates than traditional savings accounts. They combine the flexibility of regular deposits and withdrawals with the benefit of earning more on your savings.
As a Card Member, you can reach us anytime through your online account at americanexpress.com. Enjoy the convenience and flexibility of online payments. Choose to pay from up to 9 different bank accounts and schedule payments, even on the day it’s due (until 8pm MST).
Get more out of Card Membership through your Online Account
Few mild and self-limiting AEs were observed and both the drugs were well tolerated.
- Inter group analysis of the AOM-SOS scores showed that there was no statistically significant difference in the baseline, day 5 and day 10 AOM-SOS scores.
- Out of 40 children screened, 36 fulfilled the selection criteria and included in the study.
- Linking your external account can take up to two days.
- Intra group analysis of AOM-SOS score at baseline (day 0) against day 5 and day 10 scores showed a highly significant decrease in both groups and clinically significant improvement in the signs and symptoms of the PAOM.
- The clinical success rates were 93.8% in Group A and 88.2 % in Group B. These rates are comparable and no statistically significant difference was observed between the groups.
Statistical Analysis
Earn more interest than your average savings account and enjoy the convenience you expect from American Express.1 Log in or scroll down to learn about the benefits of managing your account online. Do I get an ATM card, a debit card, or checks when I open a Savings account? Earn more interest than your average savings account – and watch your money grow. High-interest savings accounts can help you save more – for whatever you save for. The clinical success rates were 93.8% in Group A and 88.2 % in Group B. These rates are comparable and no statistically significant difference was observed between the groups.
You can add offers you want to your Card online. Use your Card to pay and watch the savings and rewards add up.
Linking your external account can take up to two days. These were mild AEs and did not require modification of drug therapy. Over all safety profile of both the study drugs was good. The perspective of management of AOM has been changing continuously.
The mean age of the children in cefaclor group was 5.74 years and in amoxicillin-clavulanate potassium group was 4.93 years which is higher than our study group . Intravenous or intra-muscular administration of ceftriaxone is recommended in treatment of PAOM if amoxicillin is used within last one month for treatment of same condition . But, there is no such guideline available in India and till date no study was conducted to compare cefpodoxime, an oral third generation cephalosporin in PAOM in children below two years. Our study shows that cefpodoxime and amoxicillin-clavulanate are equally effective in clinically diagnosed cases of PAOM, both in terms of effectiveness and safety in children below two years.
Children Group B received cefpodoxime 10 mg/kg/day in two divided doses for 10 days. Children showing worsening clinical signs or treatment failure were withdrawn prematurely from the study. Apart from the study drugs, no concomitant medication was administered to the children. Safety monitoring was performed continuously throughout the study. All Adverse Effects (AE) spontaneously reported by the parents or elicited by the treating paediatrician were recorded.
Replace a Card
High dose amoxicillin exceed the Minimum Inhibitory Concentration (MIC) of S. A 4 to 6 days treatment with high dose amoxicillin and clavulanate potassium has been found effective to eradicate S. On the other side, the data show that 58% to 82% of H. Influenzae are susceptible to regular and high dose amoxicillin.
Catarrhalis obtained from upper respiratory tract are susceptible to amoxicillin-clavulanate potassium 3-5. Hoberman A et al., reported that 10 days treatment with amoxicillin-clavulanate potassium in children between 6 to 23 months of age with AOM showed resolution of signs and symptoms and decreased overall symptoms burden . American association of paediatrics also recommends amoxicillin-clavulanate potassium as the first line drug in treatment of AOM . To compare the efficacy and safety of cefpodoxime and amoxicillin-clavulanate potassium for the treatment of PAOM in children below two years. Out of 40 children screened, 36 fulfilled the selection criteria and included in the study.
Efficacy Parameter
One multi-centric prospective clinical trial compared the efficacy and safety of cefaclor and amoxicillin-clavulanate potassium in children with AOM. Both cefaclor and amoxicillin-clavulanate potassium caused a significant improvement in all the signs and symptoms after 10 days of treatment period. Inter group comparisons showed that the decrease in most of the symptoms was significantly higher in cefaclor arm as compared to amoxicillin-clavulanate potassium arm. The study showed cefaclor is well tolerated and effective treatment option for AOM in children and it is superior to the combination of amoxicillin-clavulanate potassium in efficacy and tolerability in AOM. However, the children included in the study by Agarwal M et al., were above two years of age.
These non-serious AEs did not require dose modification or withdrawal of drug therapy. Several published studies 6,11-14 show the efficacy of amoxicillin-clavulanate potassium for the treatment of PAOM. Few studies have also proved the efficacy of ceftriaxone, cefaclor and cefuroxime axetil in children with PAOM . But no published data are available that compared amoxicillin-clavulanate potassium with an oral third-generation cephalosporin like cefpodoxime in PAOM. Our study shows that efficacy and safety of 10 days therapy with cefpodoxime is comparable to that of amoxicillin-clavulanate potassium in PAOM in children below two years.
The causality analysis was done as per the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) criteria . The results of this prospective study showed that a 10-day course of cefpodoxime is therapeutically comparable to amoxicillin-clavulanate potassium in terms of both efficacy and safety for the treatment of PAOM in children below two years. Cefpodoxime is a wide spectrum oral third generation cephalosporin. It is active against aerobic Gram-positive and Gram-negative bacteria as well as anaerobic organisms.
Current research is focused towards the latest development in scientific understanding of AOM and its proper management. Improper treatment and amxoline untreated cases of AOM can lead to serious complications, especially in children under two years. The key factor to successful treatment is the choice of specific antimicrobial agent. Gradual increase of antimicrobial resistance and costs of antimicrobial therapy have emphasized the need of judicious and rational use of antimicrobial drugs 1,2.